Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and introducing revenue guidance of $12-$16 million for the …

… record-high medical cannabis revenue, adjusted EBITDA and … to international cannabis than Q4," Martin explained. … Q4 revenue and nearly 90% of its gross profit. "All of the profitability … quot;Because these are pharmaceutical products, we believe that …

… cancer breakthroughs, multinational pharma companies to revolutionize drug … Research segment. Fourth quarter and full year revenue increased 3% … our learning segment. Q4 revenue declined 5% due to … simple. First, deliver profitable revenue growth in an uncertain …

… and year-on-year revenue and profit growth. EBIT refers to … . This expansion has supported revenue diversification, as seen in … 000 registered products and 650+ pharma formulations. Its product mix … expected to be completed by Q4 FY26, with another plant …

… East region. SUN PHARMA Sun Pharmaceutical confirmed that the US … inspections are important for pharmaceutical companies as they decide … ’s announcements during its fourth-quarter earnings report. NTPC NTPC … company can now earn revenue from power generated by …

… large order books translating into revenues and earnings." ICRA … entities) in Q4 FY2025 revealed 7.6% YoY revenue growth, supported … levels (IT, FMCG and pharmaceuticals), improved on a YoY … debt levels coupled with better profitability of India Inc. in …

… the quarter ended March 2025. “Revenue growth was largely supported by … India Inc’s operating profit margin in Q4 FY2025 improved by 63 … benefits. Overall, the operating profit margin of India Inc hit … & steel, oil and gas, pharma and sugar saw a rise …

… large order books translating into revenues and earnings,” he added. … year expansion in operating profit margins in Q4 FY2025 to 18. … levels (IT, FMCG and pharmaceuticals), improved on a YoY basis … debt levels coupled with better profitability of India Inc. in …

… 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗔𝗿𝗲 - • Aurobindo Pharma, • Bristol-Myers Squibb Company, … Pharmaceuticals, Inc., • Sun Pharmaceutical Industries Limited, • Teva Pharmaceutical Industries … information on profit opportunities. This … Market report? Q4. What would …

… - Akorn Inc., Aurobindo Pharma Limited, Bayer AG, … Sanofi S.A., Takeda Pharmaceutical Company Limited, Vitruvias Therapeutics … enable stakeholders to make profitable business decisions and strengthen … regions for this Market? Q4. What is the …